Article Link: FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes June 17, ...
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin
Article Link: FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ ̵...
FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma
Article Link: FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma KENILWORTH, N.J....
FDA Grants Genentech’s Polivy (polatuzumab vedotin-piiq) Accelerated Approval for Adults With Previously Treated Aggressive Lymphoma
Article Link: FDA Grants Genentech’s Polivy (polatuzumab vedotin-piiq) Accelerated Approval for Adults With Previously Treated Aggressive Lymphoma...
PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age
Article Link: PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age ...
Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options
Article Link: Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options London UK – 06 June 2019 — GlaxoSmith...
Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
Article Link: Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention ...
FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache
Article Link: FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache INDIANAPOLIS, June 04, 2019 – Eli ...
FDA Approves Zerbaxa (ceftolozane and tazobactam) 3g Dose for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
Article Link: FDA Approves Zerbaxa (ceftolozane and tazobactam) 3g Dose for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated B...
FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma
Article Link: FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicula...
